Assyro AI

Orange Book product · Brand (NDA)

PHOSLYRA

CALCIUM ACETATE

Brand (NDA)NDA 022581DISCN FRESENIUS MEDCL CARE

At a glance

Apr 18, 2011

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Apr 18, 2011

    15 yr 5 mo ago

  2. Today

  3. Patent 8592480 expires

    Listed method-of-use patent (U-1469) expiration.

    Jul 20, 2027

    in 1 yr 1 mo

  4. Patent 9089528 expires

    Listed method-of-use patent (U-1469) expiration.

    Jul 20, 2027

    in 1 yr 1 mo

  5. Patent 8591938 expires

    Listed drug product patent expiration.

    Feb 23, 2030

    in 3 yr 9 mo

Pharmaceutical detail

Active ingredient

CALCIUM ACETATE

Strength

667MG/5ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 022581

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8592480Jul 20, 2027in 1 yr 1 mo
U-1469
9089528Jul 20, 2027in 1 yr 1 mo
U-1469
8591938Feb 23, 2030in 3 yr 9 mo
ProductU-1469
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.